Stemirna Therapeutics racks up about $200m: Reuters
Stemirna Therapeutics, a RNA technology- based drug developer, has raised about $200 million, reported Reuters.
Stemirna Therapeutics, a RNA technology- based drug developer, has raised about $200 million, reported Reuters.
Copyright PEI Media
Not for publication, email or dissemination